martes, 15 de agosto de 2017

Kenneth C. Frazier (Ceo Merck) renuncia a la Presidencia de American Manufacturing Council

.
.
(Reuters) - Merck & Co Inc Chief Executive Kenneth Frazier resigned from U.S. President Donald Trump's American Manufacturing Council on Monday, saying he was taking a stand against intolerance and extremism. 

Frazier, who is African-American, is the only CEO so far to leave one of Trump's advisory councils because of his reaction to the violence in Virginia. Prominent Democrats and Republicans criticized Trump's response to the violence over the weekend. 

A gathering of hundreds of white nationalists in Virginia took a deadly turn on Saturday when a car plowed into a group of counter-protesters and killed at least one person. 

Trump had said "many sides" were involved, drawing fire from across the political spectrum for not specifically denouncing the far right. 

"America's leaders must honor our fundamental views by clearly rejecting expressions of hatred, bigotry and group supremacy, which run counter to the American ideal that all people are created equal," Frazier said in a statement announcing his resignation.

(bit.ly/2fFnITM)


 

 "As CEO of Merck and as a matter of personal conscience, I feel a responsibility to take a stand against intolerance and extremism," he said. 

Trump responded in a tweet, saying now that "Ken Frazier of Merck Pharma has resigned from President's Manufacturing Council, he will have more time to LOWER RIPOFF DRUG PRICES!

Más

As it stands, Johnson & Johnson's Axel Gorsky is the remaining senior pharma figure on the Manufacturing Council, and as of this morning had not revealed whether or not he will remain on board.

Ver:
Merck CEO resigns from Trump post in Charlottesville protest



Frazier was among the pharma executives who met with the president shortly after he was sworn in. 
At that meeting, the president told those attending that drugmakers needed to lower prices, deliver "better" innovation and "move your companies back" to the U.S. (Más)

Ver:

Precios: Trump se reune con "top pharma execs".

Publicar un comentario